Puberty blockers get the green light

Australian authorities will recommend puberty blockers as a treatment option for some transgender and gender-diverse children, despite tighter restrictions overseas and limited evidence about the medicines’ potential benefits and risks.

The National Health and Medical Research Council (NHMRC) on Monday released interim guidance stating that puberty blockers may be considered for people under 18 experiencing “gender incongruence” — a mismatch between the sex assigned at birth and the gender with which a person identifies.

Treatment may be considered once a young person has begun puberty, has been assessed as suitable, and reaches the decision through a shared process involving the patient, their parents or carers, and clinicians.

The guidance, which is now open to public consultation, is Australia’s first nationally endorsed clinical advice on puberty blockers. It comes as the UK and an increasing number of US states move to limit access to the drugs.

Federal Health Minister Mark Butler said on Monday that the NHMRC had recommended puberty blockers could be used in carefully selected cases and subject to strict safeguards.

“The National Health and Medical Research Council advice that was published… today suggests that puberty blockers or puberty suppressants can be used in certain circumstances and subject to a range of conditions,” he said.

“Those conditions include, obviously, a process of shared decision making and consent by the young people, by clinicians, and importantly by parents.”

Butler said patients would need a comprehensive health assessment, input from multiple specialists and continued monitoring throughout treatment.

Mark Butler (pictured) said the federal government would not intervene on existing state laws. Queensland and the Northern Territory have restricted access to puberty blockers

Mark Butler (pictured) said the federal government would not intervene on existing state laws. Queensland and the Northern Territory have restricted access to puberty blockers

The interim guidance follows the government’s 2025 decision to commission national recommendations for the care of transgender and gender-diverse young people.

Butler said the debate had intensified since the publication of the independent Cass Review in the UK.

Commissioned by the UK’s National Health Service and led by paediatrician Dr Hilary Cass, the review concluded that evidence supporting puberty blockers and cross-sex hormones for children and adolescents experiencing gender distress was limited and of low quality.

It also found insufficient long-term evidence about the treatments’ benefits, risks and outcomes, prompting calls for a more cautious and evidence-based approach.

In the United States, the issue remains sharply polarised. Puberty blockers are legal in all 50 states when used for non-transgender medical conditions, but 24 states now impose restrictions or bans on their use by transgender minors.

Those restrictions follow major legislative changes and the US Supreme Court’s 2025 decision in United States v Skrmetti, which upheld states’ authority to restrict gender-affirming treatments for children.

“This is, I think it’s fair to say, an area of clinical practice that attracts a lot of public commentary and public debate, and that is understandable given we’re talking about children and adolescents, particularly children and adolescents who are often quite vulnerable,” Butler said.

The NHMRC described its recommendation as “conditional”, recognising that evidence on the benefits and risks of puberty blockers remains limited and that treatment decisions must be made on an individual basis.

The NHMRC recommended puberty blockers to be considered for people under 18 who have 'gender incongruence' (file photo of transgender flag above)

The NHMRC recommended puberty blockers be considered for people under 18 who have “gender incongruence” (file photo of transgender flag above)

The advice could increase pressure on Queensland and the Northern Territory, where access to puberty blockers and gender-affirming hormones through public health services has been restricted.

In Queensland, a ministerial direction from the Crisafulli Government prevents public hospitals from starting patients under 18 on puberty blockers or gender-affirming hormones for gender dysphoria.

Young people who were already receiving treatment before Queensland introduced its 2025 freeze can continue, while puberty blockers remain available for non-transgender conditions, including precocious puberty.

The Queensland Government has extended the restrictions until 2031, when the UK’s PATHWAYS clinical trial is due to conclude. The trial is examining the safety and effectiveness of puberty blockers.

The Northern Territory has likewise stopped new publicly funded prescriptions of puberty blockers and gender-affirming hormones for people under 18. Mental health support remains available, and private doctors may still prescribe the medicines.

When asked whether the two governments should overturn their restrictions, Butler stopped short of calling for them to do so.

“I know traditionally state governments of both political persuasions have always paid high regard to the advice of the National Health and Medical Research Council,” he said.

“Its reputation is unimpeachable, but ultimately these are decisions for state and territory governments.”

The Crisafulli Government moved to ban puberty blockers in public clinics until 2031

The Crisafulli Government moved to ban puberty blockers in public clinics until 2031

Across Australia, puberty blockers remain legal and can be prescribed by clinicians.

They are generally prescribed off-label and are not subsidised through the Pharmaceutical Benefits Scheme when used for gender-related treatment.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Home Invasion Victim Arrested After Stabbing Death; Sister Charged

The mother of a 31-year-old man fatally stabbed during an alleged home…

Missing Cat Found After Brooklyn Collapse, Reunited With Owner

A beloved cat feared lost in the rubble of a deadly Brooklyn…

SNL Mocks Nvidia CEO Jensen Huang’s Chinese Spy Affair Scandal

Saturday Night Live took aim at former Nvidia chief Jensen Huang and…

Israel Kills Top Hamas Commander Accused of Planning Terror Attacks

Israeli forces killed a senior Hamas commander who was allegedly preparing to…

Turkish husband Hakan Aysal freed after pregnant wife’s cliff death

A Turkish man convicted of killing his pregnant wife by pushing her…

United Airlines Blocks Meta AI From Booking Flights in Setback

Travelers hoping to let an AI assistant book their next flight may…

US Transport Secretary Sean Duffy Says When Airport Delays Ease

Transportation Secretary Sean Duffy said airport disruptions nationwide could be resolved by…

Pope Takes Cockpit Seat During Air Force Flight to Cusco

Pope Leo XIV climbed into the cockpit and waved to onlookers as…

Maldon Sea Salt Uses German Rock Salt Despite Essex Origin Claims

Harvested near the Essex town that gives it its name, Maldon Salt…

NYPD Fatally Shoots Kidnapping Suspect After NYC Highway Chase

Police fatally shot a kidnapping suspect on the Belt Parkway Saturday night…

Inside Bella Hadid’s Life in Cowboy Adan Banuelos’ Conservative Circles

Bleached hair, a fresh-looking tan and a hockey jersey were enough to…

Demi Moore Stuns at Baby2Baby Gala With Youthful Red Carpet Look

Demi Moore showcased her youthful appearance as she joined Kerry Washington, Jessica…